Biomedical researchers need to forge better relationships with one another, regulators and physicians, FDA Center for Drug Evaluation and Research Director Janet Woodcock told researchers attending the Breakthroughs in Medicine conference. Common diseases are being ignored as rare diseases capture more attention, and researchers should leverage sources of big data and work with clinicians to study those diseases, Woodcock said.
Woodcock urges researchers to collaborate, pay attention to common diseases
Sign up for Specialty Pharmacy SmartBrief
News affecting the specialty pharmacy industry
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.